PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ProTherImmune, Lafayette, CA, USA.\', \'Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland.\', \'Independent Expert, Silver Spring, MD, USA.\', \'Paul-Ehrlich-Institut, Langen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2022.2026742
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 35001848
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35001848>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35001848>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all